ReSolution Latin America

Executive Summary

ReSolution Latin America is a leading regional Contract Research Organization (CRO) headquartered in Buenos Aires, Argentina, with over 18 years of experience providing end-to-end clinical research services across Latin America. The company leverages its proprietary Investigator Network (ReSNET) and deep regulatory expertise to help global pharmaceutical, biotechnology, and medical device sponsors design, launch, and manage clinical trials in the region. By offering high-quality data, timely patient enrollment, and cost efficiency, ReSolution addresses the growing demand for decentralized and cost-effective clinical research outside traditional markets. The Latin American CRO market is expanding as sponsors seek to diversify trial locations, reduce costs, and accelerate timelines, positioning ReSolution for steady growth. As a private, commercial-stage company with 50–200 employees, ReSolution has built a strong reputation for operational excellence and local knowledge. Its network of investigators across multiple therapeutic areas enables rapid patient recruitment and regulatory navigation in countries like Argentina, Brazil, Mexico, and Chile. The company's focus on quality and compliance with international standards makes it an attractive partner for global trials. With the increasing trend of pharmaceutical outsourcing to Latin America, ReSolution is well-positioned to capture market share and expand its service offerings, potentially driving revenue growth and strategic partnerships.

Upcoming Catalysts (preview)

• Q3 2026Announcement of new multi-year contract with a top-20 pharmaceutical company70% success
• Q4 2026Launch of a regional oncology trial program leveraging ReSNET60% success
• Q1 2027Expansion of operations into two new Latin American countries (e.g., Colombia and Peru)50% success